Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
ResMed Inc. has reported a strong fiscal performance in the fourth quarter of 2024, with revenues up by 9% and a significant operating profit increase of 38%. The company also announced a 10% dividend increase to $0.53 per share and highlighted its leadership position in the sleep health and breathing disorders market, attributing success to solid growth across its device, mask, and software businesses.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
